[Corrigendum] New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer

【更正】老药新用:多西环素在小细胞肺癌中的抗肿瘤活性及机制

阅读:1

Abstract

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, in Fig. 3 on p. 1356 showing the results of cellular apoptosis experiments, the 'Doxy 5 µg/ml' and 'Doxy 10 µg/ml' data panels appeared to contain overlapping data, such that these images were apparently derived from the same original source where the results of differently performed experiments were intended to have been shown. In addition, in Fig. 4A on p. 1357, showing the results of TUNEL assay experiments, the 'Doxy 10 µg/ml' and '5‑FU 25 µg/ml' data panels contained overlapping sections, similarly suggesting that these data had been derived from the same original source. The authors were able to consult their original data, and recognized how these errors occurred. The corrected versions of Figs. 3 and 4, now showing the correct data for the 'Doxy 5 µg/ml' experiment in Fig. 3 and the '5‑FU 25 µg/ml' experiment in Fig. 4A, are shown below and on the next page. The authors regret the errors that were made during the compilation of the original figures, and are grateful to the editor of International Journal of Oncology for allowing them the opportunity to publish this Corrigendum. Note that the errors that were made in compiling this pair of figures did not have a significant impact on the conclusions reached in this study. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the readership for any inconvenience caused. [International Journal of Oncology 48: 1353‑1360, 2016; DOI: 10.3892/ijo.2016.3375].

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。